
Join to view full profile
30 Buxton Farm RdSte 230Stamford, CT 06905
Phone+1 203-914-1900
Dr. Tepper is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1981 - 1984
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1981 - 1984
University of Washington School of MedicineJunior Residency, 1980 - 1981
Boston University Medical CenterInternship, Internal Medicine, 1979 - 1980
Weill Cornell MedicineClass of 1979
Certifications & Licensure
NY State Medical License 1999 - 2028
CT State Medical License 1999 - 2027
PA State Medical License 2023 - 2024
VT State Medical License 2022 - 2024
NH State Medical License 2015 - 2023
OH State Medical License 2008 - 2017
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial.Uwe Reuter, Annelies Van Dycke, Jan Versijpt, Dagny Holle-Lee, Mark Kristof Farkas
The Lancet. Neurology. 2026-09-01 - Safety and tolerability of transnasal evaporative cooling for the acute treatment of migraine in an at-home setting: A randomized, double-blind, sham-controlled, decen...MaryAnn Mays, Kristina M Fanning, Stewart J Tepper
Headache. 2026-07-08 - Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the randomiz...Henrik W Schytz, Rigmor H Jensen, Christofer Lundqvist, Cristina Tassorelli, Fabrizio Vernieri
The Journal of Headache and Pain. 2026-06-13
Journal Articles
- Anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018Stewart Tepper, MD, Headache: The Journal of Head and Face Pain
- Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine TrackerDawn C Buse, Stewart J Tepper, David W Dodick, Headache: The Journal of Head and Face Pain
- Migraine: barriers for care.Sheftell FD, Tepper SJ, Bigal ME, Neurol Sci. 2005;26 Suppl 2:s140-2
Books/Book Chapters
Abstracts/Posters
- Botulinum Toxin in the Preventive Treatment of Refractory Headaches.Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM, International Headache Research Seminars, Copenhagen, Denmark
- Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)—a case report.Volcy M, Tepper SJ, Rapoport AM, Sheftell FD, Bigal MD, Cephalalgia 2005:25:470–472
- Rational Therapy for Headache.Cady RK, Rosum RW, Solomon GD, Tepper SJ, Institute for Contemporary Pharmacy Research
Lectures
- Prevention of Headache Recurrence, Migraine.American Academy of Neurology, Boston, MA
- Pathophysiology and Pharmacology of Migraine.XVI Annual US Army Medical Department Neurology Conference. Madigan Army Medical Center, Tacoma, WA
- When should we use 5HT agonists and when might they be used in preference to other treatments such as ergotamines and combination therapies, in New Horizons in Migraine.XVIth World Congress of Neurology, Buenos Aires, Argentina
Other
- Migraine: improved outcomes in patients previously poorly responsive to therapy.Dowson AJ and Tepper SJ, Int J Clinic Practice 2008;62(12):1822-1824
- Rescue Me: Rescue Medication for Migraine.Whyte C, Tepper SJ, Evans R, Headache 2010;50(2):307-313
- Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter?Katic´ BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME, Headache 2010;50(1):117-132
Press Mentions
Lundbeck Advances Leadership in Migraine with New Data at the American Headache Society 67th Annual Scientific MeetingJune 19th, 2025
FDA Okays Dihydroergotamine Nasal Spray for Acute MigraineMay 5th, 2025
FDA Approves Atzumi Nasal Powder for Acute Migraine TreatmentMay 2nd, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









